Edition:
United States

Quest Diagnostics Inc (DGX.N)

DGX.N on New York Stock Exchange

75.15USD
4:02pm EDT
Change (% chg)

$-0.02 (-0.03%)
Prev Close
$75.17
Open
$75.59
Day's High
$75.83
Day's Low
$74.92
Volume
296,065
Avg. Vol
275,287
52-wk High
$88.89
52-wk Low
$59.66

DGX.N

Chart for DGX.N

About

Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates through two businesses: Diagnostic Information Services and Diagnostic Solutions. The Company's Diagnostic Information Services business develops and delivers diagnostic testing information and services to patients, physicians,... (more)

Overall

Beta: 0.69
Market Cap(Mil.): $10,633.34
Shares Outstanding(Mil.): 141.46
Dividend: 0.40
Yield (%): 2.13

Financials

  DGX.N Industry Sector
P/E (TTM): 14.57 51.71 45.44
EPS (TTM): 5.16 -- --
ROI: 9.12 6.10 12.52
ROE: 16.83 9.55 13.40
Search Stocks

BRIEF-Quest Diagnostics gets FDA emergency use authorization for Zika test

* Received U.S. FDA emergency use authorization (EUA) for the Zika virus RNA qualitative real-time RT-PCR test

Apr 28 2016

BRIEF-Quest Diagnostics reports Q1 adjusted earnings per share $1.12

* Quest diagnostics reports first quarter 2016 financial results

Apr 21 2016

BRIEF-Quest Diagnostics CEO's 2015 total compensation was $9.7 mln vs $9.3 mln in 2014 - SEC Filing

* CEO Stephen H. Rusckowski's FY 2015 total compensation was $9.7 million versus $9.3 million in FY 2014 - SEC Filing

Apr 07 2016

BRIEF-DiaSorin to buy Focus Diagnostics immunodiagnostic and molecular diagnostic products business

* Enters agreement with Quest Diagnostics (Quest) to buy its Focus Diagnostics, Inc. immunodiagnostic and molecular diagnostic products business

Mar 30 2016

BRIEF-Quest Diagnostics announces pricing of cash tender offers for up to $200 mln

* Quest Diagnostics announces pricing of cash tender offers for up to $200 million combined aggregate principal amount of certain of its outstanding notes

Mar 28 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : ValuEngine, Inc.
$25.00
Provider : S&P Capital IQ – STARS Reports
$127.00
Provider : Stock Traders Daily
$20.00
Provider : Pechala's Reports
$25.00
Provider : Stock Traders Daily
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks